Journal
JOURNAL OF CLINICAL MICROBIOLOGY
Volume 49, Issue 9, Pages 3338-3339Publisher
AMER SOC MICROBIOLOGY
DOI: 10.1128/JCM.00268-11
Keywords
-
Categories
Funding
- Wyeth Pharmaceuticals (recently acquired by Pfizer, Inc.)
- NIH [1R56AI090844-01 ARRA]
- Department of Pathology & Laboratory Medicine at NorthShore University Health System
Ask authors/readers for more resources
A real-time PCR assay was developed targeting the bla(KPC) responsible for Klebsiella pneumoniae carbapenemase (KPC)-mediated carbapenem resistance and was validated for testing colonies or enrichment broth cultures. The assay accurately detects KPC-containing strains with high analytical specificity and sensitivity.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available
Share Paper
